Search

everythinglearnresearchcommunity

for

Search:↓

New, eco-friendly methods accurately measure TDF and FNS in a new urologic medication.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Minoxidil can increase hair density, speed up regrowth in transplanted hair, and slow down further hair loss, especially beneficial for women, young men with thinning hair, and those wanting to reconstruct the back of the scalp.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Use minoxidil or finasteride first, then try HairMax LaserComb if needed.

Follicular unit transplantation treats hair loss and restores eyebrows with short recovery and natural results.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Surgical hair restoration involves moving hair from a non-balding area to a balding area, with the transplanted hair not subject to male pattern baldness. Medications can slow hair loss and regrow some hair, but successful treatment needs careful planning, skill, and ethical responsibility due to progressive hair loss and limited donor hair.

Lasers are less favored for hair transplant surgery but show promise for hair growth in controlled trials.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Lasers and light treatments are now the most common ways to remove hair.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Many new moms lose hair after childbirth due to hormonal changes, but it usually grows back within a year.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Lasers in hair transplantation show promise but are not yet standard, with current methods causing some side effects and needles still being preferred for creating recipient sites.

Botulinum toxin may help hair loss by increasing blood flow and reducing harmful factors.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

Hair transplantation has evolved to refined techniques like FUE and FUT, with Finasteride and Minoxidil as the only other proven treatments for hair loss.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.